Literature DB >> 17038686

Use of area under the curve to characterize transmission potential after antimalarial treatment.

Fabián Méndez1, Alvaro Muñoz, Christopher V Plowe.   

Abstract

To evaluate transmission potential of Plasmodium falciparum, we use the area under the curve (AUC) of gametocyte levels after treatment as an approach to combine their duration and magnitude. Analysis of determinants of AUC was based on two main exposures: parasite clearance time (PCT) and presence of dihydrofolate reductase and dihydropteroate synthase mutations associated with sulfadoxine-pyrimethamine (SP) resistance in vitro. Exposures were determined based on the first three days after treatment with SP of 96 individuals who had malaria, cleared parasitemia by days 1-3, and were followed-up for 21 days. Using regression methods, we characterized both the heterogeneity of the presence of gametocytes (AUC > 0) and the magnitude of the AUC among those with an AUC > 0. A PCT of two or three days was associated with a substantial and highly significant odds ratio for presence of gametocytes. Among those who developed gametocytes, if their clearance time was 3 days or if they had any mutations (1 or 2) the magnitude of gametocytemia was > or = 3-fold. Methods presented are applicable to both observational studies and clinical trials assessing the effect of therapies on transmission potential.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038686

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Antimalarial activity of tulathromycin in a murine model of malaria.

Authors:  Nicolas Villarino; Joshua E Denny; Nathan W Schmidt
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

2.  Measuring resistant-genotype transmission of malaria parasites: challenges and prospects.

Authors:  Rashad Abdul-Ghani; Hoda F Farag; Amal F Allam; Ahmed A Azazy
Journal:  Parasitol Res       Date:  2014-02-22       Impact factor: 2.289

Review 3.  Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.

Authors:  Patricia M Graves; Hellen Gelband; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2015-02-19

4.  Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.

Authors:  Naman K Shah; Allan Schapira; Jonathan J Juliano; Bina Srivastava; Pia D M MacDonald; Charles Poole; Anup Anvikar; Steven R Meshnick; Neena Valecha; Neelima Mishra
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

Review 5.  Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.

Authors:  Patricia M Graves; Hellen Gelband; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2014-06-30

6.  Dynamic modulation of spleen germinal center reactions by gut bacteria during Plasmodium infection.

Authors:  Rabindra K Mandal; Joshua E Denny; Ruth Namazzi; Robert O Opoka; Dibyadyuti Datta; Chandy C John; Nathan W Schmidt
Journal:  Cell Rep       Date:  2021-05-11       Impact factor: 9.423

7.  Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.

Authors:  Theonest K Mutabingwa; Kandi Muze; Rosalynn Ord; Marnie Briceño; Brian M Greenwood; Chris Drakeley; Christopher J M Whitty
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

8.  Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.

Authors:  Mayke J A M Oesterholt; Michael Alifrangis; Colin J Sutherland; Sabah A Omar; Patrick Sawa; Christina Howitt; Louis C Gouagna; Robert W Sauerwein; Teun Bousema
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

9.  Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.

Authors:  David J Bacon; Doug Tang; Carola Salas; Norma Roncal; Carmen Lucas; Lucia Gerena; Lorena Tapia; A Alejandro Llanos-Cuentas; Coralith Garcia; Lelv Solari; Dennis Kyle; Alan J Magill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

10.  Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda.

Authors:  Alice Chijioke Eziefula; Sarah G Staedke; Shunmay Yeung; Emily Webb; Moses Kamya; Nicholas J White; Teun Bousema; Chris Drakeley
Journal:  BMJ Open       Date:  2013-03-26       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.